Leukocyte poor platelet rich plasma vs leukocyte rich platelet rich plasma as a treatment for cervical facetogenic pain: A pooled analysis.

Interv Pain Med · 2025 · PMC11929870 · PMID 40124672

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

a strong trendp = 0.053so close (0.05 < p ≤ 0.1)

Last, there was a strong trend (t(55) = −1.98, p = 0.053) for a between group difference in pain duration with the LP group showing a shorter duration of pain. 4.2 NRS – cervical facetogenic pain intensity Participants from both the LP- and LR-PRP studies presented with moderate to severe levels of pain at baseline [ 16 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.